We are live on ! Find out more
NMC

NEA Management Company Portfolio holdings

AUM $1.76B
1-Year Est. Return 223.33%
This Fund
S&P 500
This Quarter Est. Return
+63.98%
1 Year Est. Return
+223.33%
3 Year Est. Return
+769.45%
5 Year Est. Return
+668.45%
10 Year Est. Return
+14,843.34%
AUM
$1.82B
AUM Growth
+$494M
Cap. Flow
-$97.3M
Cap. Flow %
-5.34%
Top 10 Hldgs %
79.12%
Holding
32
New
–
Increased
1
Reduced
4
Closed
3

Top Buys

Rank Stock Value
1
XFOR icon
X4 Pharmaceuticals
XFOR
+$4.47M

Top Sells

Rank Stock Value
1
ACLX
Arcellx
ACLX
+$50.4M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$30.4M
3
INZY
Inozyme Pharma
INZY
+$9.75M
4
CELC icon
Celcuity
CELC
+$6M
5
ADAP
Adaptimmune Therapeutics
ADAP
+$4.09M

Sector Composition

Rank Sector Weight
1 Healthcare 91.73%
2 Consumer Staples 8.27%
3 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SYBX
26
DELISTED
Synlogic
SYBX
$4.88M 0.27%
2,922,772
– –
MRKR icon
27
Marker Therapeutics
MRKR
$18.7M
$1.45M 0.08%
1,625,678
– –
OKUR
28
OnKure Therapeutics
OKUR
$168M
$1.32M 0.07%
478,548
– –
IMA
29
ImageneBio Inc
IMA
$64.6M
$408K 0.02%
50,005
– –
ADAP
30
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-17,079,778
Closed -$4.09M
INZY
31
DELISTED
Inozyme Pharma
INZY
– –
-2,437,689
Closed -$9.75M
UP icon
32
Wheels Up
UP
$198M
– –
-5,306
Closed -$114K
1
2

Similar funds

NM
NWI Management New York $1.76B AUM 45.08% 1-Year Est. Return
SLF
Sun Life Financial Toronto, Ontario, Canada $1.76B AUM 19.57% 1-Year Est. Return
CGH
Contrarius Group Holdings Hamilton, Bermuda $1.77B AUM 83.15% 1-Year Est. Return
CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
DF
DNCA Finance Paris, France $1.75B AUM 38.18% 1-Year Est. Return
HHAM
HITE Hedge Asset Management Braintree, Massachusetts $1.77B AUM 38.67% 1-Year Est. Return
SFI
Siemens Fonds Invest Munich, Germany $1.75B AUM 26.24% 1-Year Est. Return
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

NEA Management Company's Q3 2025 Portfolio in Review

As of Q3 2025, NEA Management Company held 32 positions worth $1.82B, up 37% from $1.33B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

NEA Management Company withdrew a net $97.3M in Q3 2025, closing 3 positions and reducing 4 holdings. Its most notable exit was Inozyme Pharma, an estimated $9.75M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 92% of assets, up from 92% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, NEA Management Company added an estimated $4.47M to X4 Pharmaceuticals.

  • NEA Management Company added most to X4 Pharmaceuticals in Q3 2025, an estimated $4.47M increase.
  • NEA Management Company's biggest Q3 2025 reduction was Arcellx, cutting an estimated $50.4M.
  • NEA Management Company fully exited Inozyme Pharma in Q3 2025, selling an estimated $9.75M.
  • NEA Management Company's ten largest holdings make up 79% of its $1.82B portfolio in Q3 2025.
  • NEA Management Company opened 0 new positions and closed 3 in Q3 2025.
  • NEA Management Company's portfolio value rose 37% quarter-over-quarter to $1.82B.

Based on NEA Management Company's 13F filing for Q3 2025, filed 14 Nov 2025.